Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Rebordosa (Barcelona, Spain), A. Rubino (Cambridge, United Kingdom), A. Witzleb (Bremen, Germany), M. Olesen (Odense, Denmark), E. Plana (Barcelona, Spain), J. Aguado (Barcelona, Spain), N. Saigi (Barcelona, Spain), S. Daoud (Gaithersburg, Maryland, United States of America), A. Lei (Barcelona, Spain), S. Perez-Gutthann (Barcelona, Spain), T. Schink (Bremen, Germany), N. Kristiansen (Odense, Denmark), A. Pottegard (Odense, Denmark), E. Rivero-Ferrer (Barcelona, Spain). Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries. 2072

Member's Comments

No comment yet.

Related content which might interest you: Safety and effectiveness of indacaterol in Korean COPD patients: A post-marketing surveillance (PMS) study Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Effects of aclidinium bromide/formoterol fumarate fixed-dose combination on health status in COPD Source: International Congress 2014 – COPD markers Year: 2014 Adherence to inhaled therapies in COPD patients from 7 Latin America countries: the LASSYC study Source: International Congress 2017 – COPD management Year: 2017 Cost-effectiveness of adding budesonide/formoterol to tiotropium in severe COPD patients in four Nordic countries Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Provision of nonpharmacolocical treatment options for COPD patients in 13 European countries: Results from the European COPD audit Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 Characteristics of patients newly prescribed a long acting bronchodilator in the United Kingdom (UK) Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study Source: International Congress 2014 – New insights into the epidemiology of COPD Year: 2014 Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS) Source: International Congress 2014 – Asthma and COPD management Year: 2014 Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Changes in the use of anti-asthmatic medication in an international cohort Source: Eur Respir J 2005; 26: 1047-1055 Year: 2005 Prescription rates for various classes of COPD & asthma medication in Turkey Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001 Differences in adherence to common inhaled medications in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Real-world medication use patterns in stable COPD patients from Romania Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Use of respiratory drugs, flu vaccination and anti-smoking advice in patients with COPD from 5 Latin American cities: the PLATINO Study Source: Eur Respir J 2006; 28: Suppl. 50, 452s Year: 2006 Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries Source: Eur Respir J 2010; 35: 761-767 Year: 2010